Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 7.37
-1.47 %
$ 399 M
Market Cap
-1.88
P/E
EBS - OPERATING INCOME
Operating Income EBS - Emergent BioSolutions Inc.
-726 M
LAST VALUE
-74.93%
2 YEAR CAGR
-55.49%
5 YEAR CAGR
-33.49%
10 YEAR CAGR